Myriad Genetics, Inc. Common Stock (NASDAQ: MYGN) last traded at $3.20, down 0.62% on the session. The quote above updates while this page is open; the figures below are drawn from Myriad Genetics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Myriad Genetics, Inc. Common Stock trades on NASDAQ under the ticker MYGN. Its market capitalisation is $306.08 million.
Valuation measures for Myriad Genetics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $306.08M |
|---|---|
| Enterprise value | $525.88M |
| Price / sales | 0.38 |
| Price / book | 1.01 |
| Beta | 1.10 |
Trailing-twelve-month figures tagged in Myriad Genetics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $806.60M |
|---|---|
| Net income (TTM) | -$112.60M |
| EPS (TTM) | -$1.20 |
| Gross margin | 68.83% |
| Operating margin | -12.22% |
| Return on equity | -37.05% |
| Cash | $115.20M |
Range and volume for MYGN over the past 52 weeks.
| 52-week high | $8.59 |
|---|---|
| 52-week low | $2.74 |
| Volume | 1.27M |
| Average volume | 1.90M |
| Previous close | $3.22 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.